A free HCV Guidance App, a digital version of the HCV Guidance, for your mobile device is available for download. For more information, please click here.
What’s New and Updates/Changes
We are pleased to announce a new member to the HCV Guidance Panel! Tracy Swan is the Hepatitis/HIV Project Director for Treatment Action Group, and joins the Panel as a Community Representative.
We are pleased to announce a new member to the HCV Guidance Panel! Andrew Reynolds is the Hepatitis C Education Manager of Project Inform, and joins the Panel as a Community Representative.
A correction has been made to a typographical error in the description of the ION-4 study, in the ‘Unique Populations: Patients with HIV/HCV Section’ with regard to not recommending a shortened ledipasvir/sofosbuvir treatment course for HIV/HCV coinfected individuals.
A recent FDA alert warns against combining amiodarone with ledipasvir/sofosbuvir or with sofosbuvir taken in combination with another direct acting antiviral. This interaction has been added to the ‘Drug Interaction With Direct-Acting Antivirals and Selected Concomitant Medications’ table in the Initial Treatment section.